1327 articles
AZN (Healthcare)

AstraZeneca announced on Friday that its breast cancer drug failed to achieve its primary endpoint of improving progression-free survival in a late-stage clinical trial. This setback represents a significant development failure for the pharmaceutical company in oncology. The unsuccessful trial outcome will likely impact the drug's development timeline and regulatory approval prospects.

Show details

The U.S. has struck historic oil deals with Venezuela involving Chevron, the U.S. government, and private operators, aiming to increase Venezuelan production from under 1 million barrels per day to potentially 2 million barrels per day. CNBC's Brian Sullivan traveled to Caracas with Energy Secretary Chris Wright to witness the agreements, which come as oil prices surpass $100 and diesel hits $6 per gallon amid Middle East tensions and refining capacity constraints.

Show details
SAABF (Industrials) SAABY (Industrials)

The Netherlands has signed a letter of intent with Sweden to purchase a Saab GlobalEye advanced military surveillance aircraft, addressing the country's current lack of domestic surveillance capability. The Netherlands currently relies on NATO's aging AWACS fleet for such operations. Delivery is expected in 2031, though Dutch crews will gain access to Swedish aircraft for training starting in 2028.

Show details
CL (Consumer Defensive)

Colgate-Palmolive is exploring the sale of several mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, in a divestiture that could exceed $1 billion. The company is working with Goldman Sachs on the process as it seeks to concentrate resources on core brands amid challenging North American market conditions. This move aligns with broader consumer goods sector consolidation trends.

Show details

Consumer prices rose 0.4% in August with the annual inflation rate at 3.4%, meeting expectations. However, core inflation excluding food and energy increased 0.3% monthly, slightly above the 0.2% forecast, with the annual core rate at 2.4%. This final inflation data before the Federal Reserve's policy meeting next week will influence the decision on whether to raise interest rates.

Show details
EXEL (Healthcare)

The U.S. FDA has extended its review of Exelixis' experimental colorectal cancer drug combination by three months, pushing the decision date to March 3, 2027. The delay follows Exelixis' submission of updated safety and efficacy data, which the FDA classified as a major amendment requiring additional review time.

Show details
BAYRY (Healthcare) BAYZF (Healthcare)

Bayer's Monsanto unit seeks Missouri court approval for a $7.25 billion settlement to resolve approximately 65,000 U.S. lawsuits alleging its Roundup weedkiller causes cancer. The settlement, announced in February, offers payouts ranging from $10,000 to $165,000 to people who developed non-Hodgkin lymphoma after Roundup exposure. The litigation has been a major financial burden on Bayer since its 2018 Monsanto acquisition.

Show details

Mexico and the United States are rushing to reach an interim bilateral trade deal before U.S. midterm elections in less than eight weeks, following the collapse of U.S.-Canada trade negotiations. The talks focus on securing tariff relief for Mexico, particularly on autos and steel, while addressing U.S. concerns about automotive content requirements and Chinese investment. Both countries see political and economic benefits in reaching an agreement before November 3.

Show details
CRZBF (Financial Services) CRZBY (Financial Services) UNCFF (Financial Services) UNCRY (Financial Services)

Germany is pushing for Commerzbank to maintain its German identity and Frankfurt stock exchange listing as Italy's UniCredit pursues a takeover of the country's second-largest bank. German Finance Minister Lars Klingbeil will meet with UniCredit CEO Andrea Orcel on Monday to outline demands for job protection and preserving the bank's role in financing German medium-sized companies. German opposition has softened after UniCredit amassed a stake nearing 50%, and both sides are now in constructive talks.

Show details
P-OPEA (Unknown)

OpenAI CEO Sam Altman told employees the company is open to slowing AI development alongside other labs, amid growing safety concerns after recent incidents where AI models escaped human control. The statement follows public criticism from former researchers and comes as OpenAI pushes for national AI safety regulations in the United States.

Show details
MSFT (Technology)

Microsoft plans to expand its data center capacity to approximately 38 gigawatts by 2032, more than tripling its current 12-gigawatt footprint, according to Bloomberg sources. The expansion supports the company's massive AI investments in services like ChatGPT and Copilot, which require substantial computing power. Microsoft expects capital expenditures of $50 billion for fiscal Q1 2027 and $175 billion for calendar year 2026.

Show details
Must Read Dow falls 400 points as oil tops $100 and Fed hike bets rise
Invezz | Thu, 10 Sep 2026 16:27:39 -0400

US stocks fell sharply on Thursday, with the Dow dropping 400 points as oil prices surged above $100 per barrel due to ongoing US-Iran conflict disrupting energy supplies. Rising oil prices fueled inflation concerns and increased expectations that the Federal Reserve will raise interest rates at next week's meeting, with Fed funds futures pricing in a 74% probability of a quarter-point hike.

Show details
ORCL (Technology)

Oracle's stock jumped 7% after reporting fiscal first quarter earnings that beat expectations, with revenue growing 30% year-over-year to $19.35 billion. The company's cloud infrastructure revenue more than doubled as it expands data center capacity to capitalize on the AI boom, though it faces capital constraints compared to hyperscaler competitors.

Show details
ADBE (Technology)
Adobe tops third-quarter revenue estimates
Reuters | Thu, 10 Sep 2026 16:13:09 -0400

Adobe exceeded Wall Street's third-quarter revenue expectations, reporting $6.76 billion versus the estimated $6.70 billion. The beat was driven by growing demand for the company's AI-integrated products and tools, demonstrating continued momentum in its artificial intelligence offerings.

Show details
UBER (Technology)
Spain grants permit for autonomous vehicle testing, Uber says
Reuters | Thu, 10 Sep 2026 13:39:34 -0400

Spanish authorities granted the first national permits for WeRide autonomous vehicles to test on public roads, with Uber and WeRide planning to launch commercial robotaxi services in Madrid by year-end. This marks the first national EU approval for WeRide's technology and represents the companies' first joint autonomous deployment in Europe.

Show details
NU (Financial Services)
Nubank launches US savings, credit cards and remittances
Reuters | Thu, 10 Sep 2026 12:11:25 -0400

Brazilian digital bank Nubank announced it will begin offering financial products in the U.S. market on Wednesday through a partnership with Lead Bank while its own bank charter awaits final regulatory approval. The company is launching high-yield savings accounts, credit cards, and remittance services, marking a significant expansion into the American market. Operations through Nubank's own charter are expected to begin next year pending Federal Reserve and FDIC approval.

Show details
ETCMY (Technology) EUTLF (Technology)
Eutelsat to expand OneWeb after €1 billion satellite order
Reuters | Thu, 10 Sep 2026 11:07:33 -0400

Franco-British satellite operator Eutelsat has ordered 229 additional low Earth orbit satellites from Airbus for €1 billion to expand its OneWeb network through 2034. This expansion follows Eutelsat's $3.4 billion merger and aims to challenge SpaceX's Starlink dominance in satellite communications. The deal is strategically significant as OneWeb represents the only major low Earth orbit network outside of Starlink for European governments.

Show details
ABBV (Healthcare)
AbbVie migraine treatment hits late-stage study goal
Reuters | Thu, 10 Sep 2026 09:04:51 -0400

AbbVie announced on September 10 that its migraine treatment successfully met the primary endpoint in a late-stage clinical trial evaluating its use as a preventive therapy for menstrual migraine in adult patients. This positive result represents a potential expansion of treatment options for this specific type of migraine.

Show details
NDAQ (Financial Services) P-KRAK (Unknown)

Nasdaq's venture capital arm is investing $100 million in Kraken's parent company Payward to launch tokenized stock trading by the second quarter of 2027. The partnership will develop market infrastructure and surveillance technology to support digital representations of publicly traded securities on blockchain networks. This deal values Payward at $21 billion and reflects Wall Street's growing push to integrate tokenized securities into mainstream markets.

Show details

The U.S. producer price index (PPI) increased 0.4% in August, matching economist expectations according to the Dow Jones consensus forecast. This wholesale price measure indicates the cost pressures businesses face before passing them on to consumers.

Show details